reports
- ABGSC Services Research
- Peter Sehested
- Oliver Metzger
- Wim Gille
ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 18/09/2024
La prochaine acquisition de Campari pourrait être en Inde et intervenir rapidement, selon nous. Rapidement d’abord pour que le groupe puisse pleinement profiter du dynamisme de ce marché. Rapidement ensuite pour se prémunir du ralentissement actuel des liqueurs et apéritifs (L&A) en Europe, segment dont il est historiquement très dépendant. Malgré l’intérêt stratégique du marché indien, une telle opération de M&A pourrait se révéler risquée en s’ajoutant aux multiples défis opérationn...
DGE DIAGEO PLC
MTX MTU AERO ENGINES AG
RI PERNOD RICARD SA
HO THALES SA
RCO REMY COINTREAU SA
FGA FIGEAC AERO SA
RHM RHEINMETALL AG
PHIA KONINKLIJKE PHILIPS N.V.
FII LISI SA
ISP INTESA SANPAOLO S.P.A.
SAF SAFRAN S.A.
AIR AIRBUS SE
BOL BOLLORE SA
BA. BAE SYSTEMS PLC
UCG UNICREDIT S.P.A.
SKF B SKF AB CLASS B
LDO LEONARDO SPA
HAG HENSOLDT AG
CPR DAVIDE CAMPARI-MILANO N.V.
AERO MONTANA AEROSPACE AG
UMG UNIVERSAL MUSIC GROUP NV
AM DASSAULT AVIATION
DTG DAIMLER TRUCK
LAT LATECOERE
R3NK RENK GROUP AG
- Oliver Metzger
- Wim Gille
ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 09/18/2024
Campari’s next acquisition might be in India and could materialise quickly, in our view. Speed is of the essence: first so that the group can take full advantage of the dynamic growth of this market; and second to guard against the current slowdown in liqueurs and aperitifs (L&A) in Europe, a segment on which it has historically been very reliant. Despite the strategic value that the Indian market offers, such an M&A deal could prove risky by adding to the multiple operational challen...
DGE DIAGEO PLC
MTX MTU AERO ENGINES AG
RI PERNOD RICARD SA
HO THALES SA
RCO REMY COINTREAU SA
FGA FIGEAC AERO SA
RHM RHEINMETALL AG
PHIA KONINKLIJKE PHILIPS N.V.
FII LISI SA
ISP INTESA SANPAOLO S.P.A.
SAF SAFRAN S.A.
AIR AIRBUS SE
BOL BOLLORE SA
BA. BAE SYSTEMS PLC
UCG UNICREDIT S.P.A.
SKF B SKF AB CLASS B
LDO LEONARDO SPA
HAG HENSOLDT AG
CPR DAVIDE CAMPARI-MILANO N.V.
AERO MONTANA AEROSPACE AG
UMG UNIVERSAL MUSIC GROUP NV
AM DASSAULT AVIATION
DTG DAIMLER TRUCK
LAT LATECOERE
R3NK RENK GROUP AG
- Olfa Taamallah
- Yan Derocles
MTX MTU AERO ENGINES AG
HO THALES SA
CEN GROUPE CRIT SA
ALCLA CLASQUIN SA
FGA FIGEAC AERO SA
RHM RHEINMETALL AG
FII LISI SA
ALCAR CARMAT SA
SAF SAFRAN S.A.
AIR AIRBUS SE
BA. BAE SYSTEMS PLC
DLG DE'LONGHI S.P.A.
LDO LEONARDO SPA
RUI RUBIS SCA
ALCUR ARCURE SA
HAG HENSOLDT AG
AERO MONTANA AEROSPACE AG
AM DASSAULT AVIATION
LAT LATECOERE
R3NK RENK GROUP AG
- Bruno Bulic
- Oscar Haffen Lamm
Valneva: Ixchiq label extension to include adolescents
Valneva today announced that it will seek, as expected, a label extension for its Chikungunya vaccine Ixchiq in Europe and Canada, to now also include age group 12 to 17 years. The vaccine is currently approved in Europe, US and Canada for individuals 18 years of age and older. The label extension
- Olfa Taamallah
- Yan Derocles
ODDO : Rumeurs de cessez-le-feu en Ukraine: attention au sociétés expo...
>Des rumeurs de cessez-le-feu en Ukraine qui se multiplient - Un article de Bloomberg a ravivé hier les rumeurs de discussions pouvant amener à une fin négociée du conflit en Ukraine. Sans citer de sources, les journalistes rapportaient que certains alliés commençaient à discuter de la manière dont le conflit pouvait se terminer et que la période entre les élections présidentielles américaines et l’investiture (entre novembre et janvier) pourrait offrir une fenêtre d’...
- Olfa Taamallah
- Yan Derocles
ODDO : Rumours of a ceasefire in Ukraine: watch out for groups exposed...
>Rumours of a ceasefire in Ukraine are multiplying - An article in Bloomberg yesterday revived rumours of talks aimed at negotiating an end to the conflict in Ukraine. Without citing any sources, journalists report that certain allies were beginning to discuss the manner in which the conflict could be brought to an end and that the period between the US presidential elections and investiture (between November and January) could offer a window of opportunity. Last Sund...
Valneva Submits Label Extension Applications for its Chikungunya Vacci...
Valneva Submits Label Extension Applications for its Chikungunya Vaccine, IXCHIQ®, to EMA and Health Canada To potentially include adolescents and antibody persistence up to two years Saint Herblain (France), September 18, 2024 – (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it has submitted label extension applications to the European Medicines Agency (EMA) and Health Canada to potentially expand the use of its chikungunya vaccine, IXCHIQ®, to adolescents aged 12 to 17 years in Europe and Canada. The Canadian label extension application also inc...
ISS AS: 1 director
A director at ISS AS sold 12,310,099 shares at 126.730DKK and the significance rating of the trade was 81/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
Transactions by persons discharging managerial responsibilities
Transactions by persons discharging managerial responsibilities Company Announcement Copenhagen, 17 September 2024 No. 47/2024 Transactions by persons discharging managerial responsibilities ISS A/S, a leading workplace experience and facility management company, announced on 17 September 2024 a Major Shareholder Announcement, see company announcement no. 46/2024. Consequently, ISS A/S has received notification pursuant to article 19 of the Market Abuse Regulation of transactions in ISS A/S’ shares made by persons discharging managerial responsibil...
Major Shareholder Announcement
Major Shareholder Announcement Company Announcement Copenhagen, 17 September 2024 No. 46/2024 Major Shareholder Announcement ISS A/S, a leading workplace experience and facility management company, hereby announces that ISS A/S has been informed that Lind Value II ApS and KIRKBI Invest A/S have entered into a trade of shares in ISS A/S whereby KIRKBI Invest A/S has sold 12,310,099 shares in ISS A/S to Lind Value II ApS. As a result of the transaction, Lind Value II ApS has notified ISS A/S that its aggregate holding of shares now amounts to 18,566,823 co...
Transactions in connection with share buyback programme
Transactions in connection with share buyback programme Company Announcement Copenhagen, 16 September 2024 No. 45/2024 Transactions in connection with share buyback programmeISS A/S, a leading workplace experience and facility management company, announced on 22 February 2024 a new share buyback programme, see company announcement no. 4/2024. The share buyback programme is executed in accordance Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 (the “Market Abuse Regulation”) and the Commission Delegated Regulation (EU) 2016...
- Ana Arjona-Martinez
- Chaima Ferrandon
- Sven Edelfelt
- Ana Arjona-Martinez
- Chaima Ferrandon
- Sven Edelfelt
- Bruno Bulic
- Oscar Haffen Lamm
Valneva successfull EUR 61m capital increase
Valneva today announced the issuing of 22.6m new ordinary shares at a 15% discount to last trading price, translating into EUR 61.2m fresh capital.Valneva indicated that the funds will be allocated to development of the clinical program (Ixchiq Phase III pediatric and Phase IV) and progression into
- Damien Choplain
- Martial Descoutures
Valneva : Capital increase of € 60m
>Financed to achieve profitability - The company announces the launch of a capital increase of c. € 60m through the issuance of 22.6 million shares at a price of € 2.66, i.e. a discount of c. 15% vs the last closing price. Valneva plans to use the proceeds to fund the paediatric phase III trial and phase IV trials of its chikungunya vaccine as well as the anticipated phase 2 programmes for the Shigellosis and Zika virus vaccine candidates. A portion of the financing w...
Valneva Announces the Success of its Private Placement Raising approxi...
Valneva Announces the Success of its Private Placement Raising approximately €60 Million Saint-Herblain (France), September 13, 2024 – (Nasdaq: VALN; Euronext Paris: VLA) (“Valneva” or the “Company”), a specialty vaccine company, today announces the successful pricing of its Private Placement (as defined below) for a final amount of €61,180,000. Peter Bühler, Valneva’s Chief Financial Officer, commented, “We would like to thank our existing shareholders for their continued support, as well as the new healthcare specialist investors joining us through this raise. In addition to supporting ...
- Damien Choplain
- Martial Descoutures
Valneva : Augmentation de capital de 60 M€
>Financée pour atteindre la profitabilité - La société annonce le lancement d’une augmentation de capital de c. 60 M€ via l’émission de 22.6M d’actions au prix de 2.66 € soit une décote de c. 15% par rapport au dernier au dernier cours de clôture. Valneva envisage d’utiliser cette somme pour financer l’essai pédiatrique de Phase 3 et les essais de Phase 4 de son vaccin contre le chikungunya ainsi que les phases 2 anticipées de ses programmes pour les candidats vaccins...
Valneva Announces the Launch of a Private Placement of Ordinary Shares...
Valneva Announces the Launch of a Private Placement of Ordinary Shares for Approximately 60 Million Euros Saint-Herblain (France), September 12, 2024 – (Nasdaq: VALN; Euronext Paris: VLA) (“Valneva” or the “Company”), a specialty vaccine company, today announces its intention to issue, subject to market conditions, approximately 22.6 million new ordinary shares (the “Offer Shares”) at a price of €2.66 per Offer Share to certain categories of investors via a private placement through an accelerated bookbuilding process starting immediately. Context of the Offering The Issuer intends to...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.